Skip to content

Clinical trials

Phase 2 Ischemia trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Ischemia Phase: Phase 2 Clear all

41 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20033
20042
20054
20062
20074
20081
20093
20102
20115
20121
20153
20163
20172
20181
20211
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed31
Terminated5
Unknown status3
Withdrawn2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Heart, Lung, and Blood Institute (NHLBI)3
AnGes USA, Inc.2
Dart NeuroScience, LLC2
Region Skane2
Sangart2
Affiliated Hospital to Academy of Military Medical Sciences1
Aldagen1
Astellas Pharma Inc1
Beijing Northland Biotech. Co., Ltd.1
Castillo, José, M.D.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Ischemia41
Stroke14
Ischemic Stroke9
Coronary Artery Disease8
Peripheral Vascular Diseases5
Arterial Occlusive Diseases4
Brain Ischemia4
Cardiovascular Diseases4
Chronic Limb-Threatening Ischemia4
Brain Infarction3

Trials

Showing 26 to 41 of 41. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.